IPOPLUS

32.31

+0.13 +0.40%

17 Jun 2026

NSE Listed · Pharmaceuticals

Ambalal Sarabhai Ent Limited (AMBALALSA)

Volume: 22,560Avg Vol 1W: 62,632Avg Vol 1M: 82,28252W Range:30.338.5
₹32.31 0.40%
Key Ratios
Updated 3h ago
Market Cap
Current Price₹32.31
Previous Close₹32.18
High / Low (52w)₹38.5 / ₹30.3
Volume22,560
Avg Vol (1W)62,632
Avg Vol (1M)82,282
Stock P/E54.77
Book Value₹20.66
Dividend Yield
ROE6.05%
ROA
Revenue (TTM)
Revenue Growth
Profit Margin
Total Debt
Shares Outstanding
Face Value₹10
EPS (TTM)₹0.85
P/B1.57
Debt / Equity0.35
50 DMA₹33.23
200 DMA₹30.12
Day change+0.40%
Price Chart
32.31 12.11% · 1Y
49244.1L
2025-06-17
2026-06-16

20-day avg volume: 76K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 13% YoY.
Cons
  • Stock trades at a high P/E of 55.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹65 Cr₹52 Cr₹44 Cr₹40 Cr₹65 Cr₹46 Cr₹45 Cr₹41 Cr₹54 Cr₹43 Cr₹40 Cr₹36 Cr₹44 Cr₹35 Cr₹47 Cr₹44 Cr₹54 Cr₹43 Cr₹56 Cr₹43 Cr₹48 Cr₹46 Cr₹42 Cr₹27 Cr₹39 Cr
EBITDA₹7 Cr₹6 Cr₹1 Cr₹9 Cr₹6 Cr₹4 Cr₹3 Cr₹2 Cr₹10 Cr₹3 Cr₹3 Cr₹-3 Cr₹7 Cr₹4 Cr₹3 Cr₹4 Cr₹9 Cr₹6 Cr₹11 Cr₹37 Cr₹19 Cr₹2 Cr₹5 Cr₹1 Cr₹16 Cr
Net Profit₹7 Cr₹4 Cr₹-1 Cr₹8 Cr₹0 Cr₹2 Cr₹3 Cr₹0 Cr₹9 Cr₹1 Cr₹1 Cr₹-5 Cr₹6 Cr₹3 Cr₹1 Cr₹2 Cr₹8 Cr₹4 Cr₹10 Cr₹27 Cr₹16 Cr₹2 Cr₹11 Cr₹1 Cr₹13 Cr
EPS0.850.4-0.071.07-0.040.290.340.051.180.150.14-0.640.720.40.130.210.990.461.243.472.030.261.410.121.68
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹208 Cr₹184 Cr₹183 Cr₹239 Cr₹194 Cr₹158 Cr
EBITDA₹15 Cr₹13 Cr₹18 Cr₹65 Cr₹26 Cr₹20 Cr
Net Profit₹5 Cr₹6 Cr₹11 Cr₹47 Cr₹29 Cr₹14 Cr
EPS0.640.741.496.163.831.83
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹270 Cr₹250 Cr₹246 Cr₹231 Cr₹210 Cr₹186 Cr
Total Liabilities₹130 Cr₹113 Cr₹115 Cr₹111 Cr₹136 Cr₹142 Cr
Equity₹140 Cr₹136 Cr₹131 Cr₹120 Cr₹74 Cr₹45 Cr
Total Debt₹8 Cr₹9 Cr₹10 Cr₹3 Cr₹5 Cr₹5 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹-14 Cr₹13 Cr₹10 Cr₹15 Cr₹0 Cr₹-4 Cr
Investing₹13 Cr₹-5 Cr₹-17 Cr₹5 Cr₹10 Cr₹17 Cr
Financing₹-2 Cr₹-3 Cr₹9 Cr₹-19 Cr₹-6 Cr₹-14 Cr
Free Cash Flow₹-14 Cr₹13 Cr₹10 Cr₹15 Cr₹0 Cr₹-4 Cr
Shareholding
Promoter 31.36% Institutions 0.01% Public 68.64%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search